Ripple Therapeutics Corp.
$22,984.00 CAD
≈ 4 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2022-2023
- Agreement period
- September 1, 2022 – January 31, 2023
- Reference
- nrc-cnrc:172-2022-2023-Q2-995494
Published purpose
Ripple Therapeutics Corporation is a clinical stage, privately held company that is focused on ophthalmic therapeutics with controllable, sustainable drug delivery. Scientific and engineering resources will perform work on the development of a novel compound for the treatment of Neovascular age-related macular degeneration (nAMD). The project will require synthesizing novel compounds and performing materials characterization and in vitro evaluations to assess for potential lead compounds for the next stages of development.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions